Synthesis and molecular docking study of N-alkyl/aryl-2-aryl indol-3-yl glyoxylamides as novel anticancer agents

Jagadeesh, N. M. and Mahadevan, K. M. and Kumara, M. N. and Prashantha, N. (2014) Synthesis and molecular docking study of N-alkyl/aryl-2-aryl indol-3-yl glyoxylamides as novel anticancer agents. International Journal of Pharmacy and Pharmaceutical Sciences, 6 (SUPPL.). pp. 921-926. ISSN 0975-1491

Text (Full Text) YUV_Che_2014_Kumara.pdf - Published Version Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Objective: To synthesize structurally distinct N-alkyl/aryl-2-aryl indol-3yl-glyoxylamides to evaluate their anticancer activity on Murine double minutes-2(MDM2) receptor bind p53 and Pheripheral benzodiazepine receptor (PBR) protein. Methods: A series of new appropriately N-alkyl/aryl-2-aryl indol-3-yl glyoxylamides (2a-h), were synthesized by the reaction of 2-arylindoles, oxalyl chloride and different amines in one pot reaction. Structure of all the new compounds were elucidated by spectral analysis and evaluated in silico docking study with MDM2 receptor bind p53 and PBR protein. Results: Among all the tested compounds, the 2-2-(4-chlorophenyl)-1H-indol-3-yl-2-oxo-N-propylacetamide (2e) showed high binding affinity on MDM2 receptor bind p53 protein. While remaining, the 2-(5-chloro-2-phenyl-1H-indol-3-yl)-N-(2,4-dimethylphenyl)-2-oxoacetamide (2a), N-(4- fluorophenyl)-2-2-(4-methylphenyl)-1H-indol-3-yl-2-oxoacetamide (2b) and 2-2-(4-methylphenyl)-1H-indol-3-yl-2-oxoacetamide (2c) were shown comparably good binding affinity on PBR protein. Conclusion: The Docking study of newly synthesized compounds revealed that the N-alkyl/aryl-2-aryl indol-3yl-glyoxylamides could be a very useful scaffold for anticancer therapy particularly on MDM2 receptor bind p53 and PBR protein.

Item Type:	Article
Uncontrolled Keywords:	antineoplastic agent, drug synthesis, unclassified drug, drug structure, molecular docking, binding affinity, article, pharmacophore, spectroscopy, protein structure, protein p53, 2 (5 chloro 2 phenyl 1 h indol 3 yl) n (2, 2 (5 chloro 2 phenyl 1 hindol 3 yl) n (2, 2 2 (4 bromophenyl) 1 h indol 3 yl n butyl 2 oxoacetamide, 2 2 (4 chlorophenyl) 1 h indol 3 yl 2 oxo n (tetrahydro 2 h pyran 4 yl)acetamide, 2 2 (4 chlorophenyl) 1 h indol 3 yl 2 oxo n propylacetamide, 2 2 (4 chlorophenyl) 1 h indol 3 yl n (2, 2 2 (4 methylphenyl) 1 h indol 3 yl 2 oxoacetamide, 4 dimethylphenyl) 2 oxoacetamide, benzodiazepine receptor, n (4 fluorophenyl) 2 2 (4 methylphenyl) 1 h indol 3 yl 2 oxoacetamide, n alkyl 2 aryl indol 3 yl gloxylamide, n aryl 2 aryl indol 3 yl gloxylamide, n butyl 2 2 (4 chlorophenyl) 1 h indol 3 yl 2 oxoacetamide, protein MDM2
Subjects:	C Chemical Science > Chemistry
Divisions:	Yuvaraj college > Chemistry
Depositing User:	Arshiya Kousar Library Assistant
Date Deposited:	25 Jun 2019 05:36
Last Modified:	11 Dec 2019 05:38
URI:	http://eprints.uni-mysore.ac.in/id/eprint/3729

Actions (login required)

View Item